Analysis and Perspectives

Sep 29, 2023

With rise of gene therapy and other innovative therapeutic approaches, we experience profound change in Netherton syndrome treatment space.

Sep 27, 2023

It is not surprising that the healthcare sector is undergoing a significant transition in an era characterized by technological developments and the digitization of almost every aspect of our lives. The development of smart medical devices is a shining illustration of how technology has advanced in healthcare in a ...

Sep 22, 2023

FDA approved GSK's momelotinib, marketed under name Ojjaara, for management of myelofibrosis in adult patients suffering from anemia.

Sep 20, 2023

Sleep Aids Market: Examining Cutting-Edge Technologies and Scientific Breakthroughs Sleep can be burdensome when it disrupts daily routines, requires a significant time commitment, and is marred by sleep disorders or disturbances that affect overall well-being. In today's fast-paced world, where stress, anxiety,...

Sep 18, 2023

Huntington’s disease is an incurable, rare genetic, progressive neurodegenerative disorder. According to the National Organization for Rare Disorders (NORD), about 30,000 people in the United States have Huntington’s disease, and another 200,000 are at risk of developing the condition. As per DelveInsight analy...

Sep 15, 2023

The dynamics of the myelodysplastic syndrome treatment market are anticipated to change in the coming years owing to the emerging therapies.

Sep 04, 2023

As per Delveinsight, the Fabry disease treatment market is likely boost enormous contribution from conventional enzyme replacement therapies.

Aug 25, 2023

There have been tremendous advancements in homozygous familial hypercholesterolemia treatment, yet several unmet needs are to be fulfilled.

Aug 21, 2023

On August 04, 2023, the FDA has approved Biogen and Sage Therapeutics' Zuranolone as the first tablet for postpartum depression treatment.

Aug 18, 2023

On 4 August 2023, FDA has approved Iveric Bio’s Izervay as the treatment of geographic atrophy secondary to age-related macular degeneration.